Cortexyme, Inc. Gains 21.53%

Tue, Aug 10, 2021 at 05:30 PM
Cortexyme, Inc. Gains 21.53%

Cortexyme, Inc. (CRTX:NASDAQ) soared at $120.21, a gain of 21.5%. On Mon, Aug 09, 2021, CRTX:NASDAQ hit a New 2-Week High of $98.91. The stock appeared on our News Catalysts scanner on Mon, Aug 09, 2021 at 09:42 AM in the 'INVESTOR UPDATE' category. From Mon, Jul 26, 2021, the stock recorded 60.00% Up Days and 63.64% Green Days

About Cortexyme, Inc. (CRTX:NASDAQ)

Cortexyme Inc is a clinical stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic virulence factor proteases, called gingipains.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.